Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruggero De Maria

Showing results (11-20 of 236) with videos related to

Pageof 24
Sort By:
Nature Reviews. Drug Discovery|January 30, 2016
Epithelial-mesenchymal transition: a new target in anticancer drug discoveryFabrizio Marcucci, Giorgio Stassi, Ruggero De Maria
Oncotarget|December 7, 2017
Replication stress in colorectal cancer stem cellsGwenola Manic, Ruggero De Maria, Ilio Vitale
Frontiers in Immunology|November 14, 2024
Oncolytic virus and CAR-T cell therapy in solid tumorsEleonora Ponterio, Tobias Longin Haas, Ruggero De Maria
Current Opinion in Pharmacology|May 22, 2017
Cancer stem cells: at the forefront of personalized medicine and immunotherapyMicol E Fiori, Lidia Villanova, Ruggero De Maria
Tumori|April 21, 2016
Alleanza Contro il Cancro: the accreditation system of the Excellence Network of Italian Cancer Centers in the precision medicine eraFabio Palombo, Paolo De Paoli, Ruggero De Maria
Frontiers in Immunology|October 26, 2020
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous VentureEleonora Ponterio, Ruggero De Maria, Tobias Longin Haas
Cancer Letters|February 15, 2011
Targeting apoptosis pathways in cancer stem cellsMichele Signore, Lucia Ricci-Vitiani, Ruggero De Maria
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2011
Cancer stem cells and chemosensitivityMarcello Maugeri-Saccà, Paolo Vigneri, Ruggero De Maria
Molecular Cancer Therapeutics|July 31, 2012
DNA damage repair pathways in cancer stem cellsMarcello Maugeri-Saccà, Monica Bartucci, Ruggero De Maria
Frontiers in Oncology|June 2, 2012
Therapeutic targeting of cancer stem cellsMarcello Maugeri-Saccà, Ann Zeuner, Ruggero De Maria
Pageof 24

Showing results (11-20 of 236) with videos related to

Sort By:
Pageof 24
Nature Reviews. Drug Discovery|January 30, 2016
Epithelial-mesenchymal transition: a new target in anticancer drug discoveryFabrizio Marcucci, Giorgio Stassi, Ruggero De Maria
Oncotarget|December 7, 2017
Replication stress in colorectal cancer stem cellsGwenola Manic, Ruggero De Maria, Ilio Vitale
Frontiers in Immunology|November 14, 2024
Oncolytic virus and CAR-T cell therapy in solid tumorsEleonora Ponterio, Tobias Longin Haas, Ruggero De Maria
Current Opinion in Pharmacology|May 22, 2017
Cancer stem cells: at the forefront of personalized medicine and immunotherapyMicol E Fiori, Lidia Villanova, Ruggero De Maria
Tumori|April 21, 2016
Alleanza Contro il Cancro: the accreditation system of the Excellence Network of Italian Cancer Centers in the precision medicine eraFabio Palombo, Paolo De Paoli, Ruggero De Maria
Frontiers in Immunology|October 26, 2020
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous VentureEleonora Ponterio, Ruggero De Maria, Tobias Longin Haas
Cancer Letters|February 15, 2011
Targeting apoptosis pathways in cancer stem cellsMichele Signore, Lucia Ricci-Vitiani, Ruggero De Maria
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2011
Cancer stem cells and chemosensitivityMarcello Maugeri-Saccà, Paolo Vigneri, Ruggero De Maria
Molecular Cancer Therapeutics|July 31, 2012
DNA damage repair pathways in cancer stem cellsMarcello Maugeri-Saccà, Monica Bartucci, Ruggero De Maria
Frontiers in Oncology|June 2, 2012
Therapeutic targeting of cancer stem cellsMarcello Maugeri-Saccà, Ann Zeuner, Ruggero De Maria
Pageof 24